R&D Pipeline

Pipeline (2021-2030)

Neurology - rProtein (3)

Modality Indication Targets Stage Company Project No. Detail
1 Nonclinical Study to Support IND Submission for ZC311, a Novel Lysosome-Activating Small Peptide Therapeutic Candidate for Amyotrophic Lateral Sclerosis (ALS)
rProtein ALS lysosome Preclinical Zincure Corp. RS-2026-25502282
2 Discovery the preclinical candidate for amyotrophic lateral sclerosis (ALS) based on the activation of lysosomes using small-molecular proteins
rProtein Amyotrophic lateral sclerosis Zn2+ Candidate ZINCURE RS-2023-00218770
3 Discovery of a novel lead compound for chronic pain treatments using a TRPV1 binding peptides design and manufacture platform
rProtein Chronic Pain TRPV1 Lead Gachon University RS-2022-00167087